Understanding PIQRAY

PIQRAY® (alpelisib) tablets + fulvestrant

PIQRAY + fulvestrant is for postmenopausal women, or men, who:


What is PIQRAY?

PIQRAY is the first and only treatment option specifically for PIK3CA mutations in HR+, HER2- metastatic breast cancer (mBC). It's a biomarker-driven treatment approach, which means that your doctor will test your breast cancer for an abnormal PIK3CA gene to make sure that PIQRAY is right for you. Learn more about PIK3CA mutation testing.

Metastatic breast cancer and PIK3CA mutation statistics Metastatic breast cancer and PIK3CA mutation statistics

If you have a PIK3CA mutation and progressed on or after hormone therapy, PIQRAY may be right for you.

You didn't choose metastatic breast cancer, but you still have choices to make. Learn more about PIQRAY and how knowing your options can help you and your doctor to pick the right treatment for your specific type of mBC.